Life sciences and health tech news roundup: Cancer care, layoffs, fundings, more

Fred Hutchinson Most cancers Exploration Center is now Fred Hutchinson Cancer Middle. (Fred Hutch Photograph / Robert Hood)

The 7 days in everyday living sciences in the Pacific Northwest ended with an announcement several years in the earning: The UW and Fred Hutch tightened their romance to extra closely combine most cancers treatment and exploration.

With a greater umbrella, Fred Hutchinson Most cancers Analysis Center has a new title: Fred Hutchinson Most cancers Center. The arrangement also consists of a re-structured romantic relationship with Seattle Children’s.

The new arrangement will far better connect the lab and the clinic, tighten collaborative associations and, speed scientific trials—which will advantage sufferers, but also has the probable to foster new spinouts in Seattle.

And there’s a new Fred Hutch spinout in city, Affini-T Therapeutics, which not long ago lifted $175 million. In an job interview, Fred Hutch researcher Phil Greenberg shared his views with GeekWire about operating correctly with his new field associate.

More headlines beneath, together with well being tech news about a Seattle startup’s new partnership with Yelp.  

— Biotech vet Phil Greenberg on his new most cancers-battling startup and immunotherapy’s future section

Yelp expands wellbeing ratings for dining establishments, with assistance from Seattle startup

Silverback Therapeutics shuts down oncology plan, plans to lay off 27% of workforce

Funding Information: Enzyme structure startup lands $33M addiction recovery company raises $3M

Newest drama at Athira: Trader phone calls for CEO alternative and would like two board seats

Philip Greenberg (heart entrance) and customers of his lab at Fred Hutch. (Fred Hutch Image)

Here’s other lifetime sciences information from throughout the Pacific Northwest and further than:

  • A lot more than 20 yrs just after the to start with headlines lauding the completion of the human genome, it is at last accomplished. The “dark” portions of the sequence, its far more obscure components — centromeres, telomeres, names familiar to the faithful — are entire. Its fleet of repetitive DNA is performed. Geneticist Evan Eichler and other UW scientists assisted direct the effort. Seattle’s Institute for Systems Biology also contributed.
  • Amazon World-wide-web Solutions released a collaboration with Raleigh-Durham, N.C.-primarily based Thread Analysis to decentralize medical trials and make them more economical.
  • Impel Neuropharma’s business start of its recently-accredited migraine treatment was “effective,” the company reported in its newest earnings report. The business also not long ago pulled in $100 million in new funding to transfer the solution ahead.
  • Bothell, Wash.-based mostly Seagen is rising. The company posted a 38% raise in solution profits more than final 12 months, reaching $1.4 billion.
  • AGC Biologics, also Bothell-based mostly, is building substance for a vaccine towards peanut allergy. The drug company will make the solution at its Heidelberg facility with its biotech lover.
  • Fred Hutch researchers Jesse Bloom and Tyler Starr discussed how the COVID-19 virus is possible to evolve in the potential, in a commentary in the New York Moments with their colleagues.
  • Vancouver, Clean.-centered Cytodyn is in issues with the Food and drug administration (it is occurred before). The agency has put scientific holds on two of its clinical trials, for HIV and COVID-19.
  • Village Get to was component of a latest tranche of gifts by billionaire Seattle philanthropist MacKenzie Scott. The Seattle nonprofit received $20 million to progress its perform providing COVID-19 vaccines and other wellbeing products and services to beneath-attained communities.
  • Prolonged time Seattle biotech journalist and adventurer Luke Timmerman left on his most current quest: Trekking to Everest foundation camp with a host of lifetime science leaders to elevate money for Fred Hutch.